Clinical Trial Details
— Status: Enrolling by invitation
Administrative data
NCT number |
NCT04712318 |
Other study ID # |
EHospitalPristina |
Secondary ID |
|
Status |
Enrolling by invitation |
Phase |
N/A
|
First received |
|
Last updated |
|
Start date |
June 1, 2016 |
Est. completion date |
June 1, 2024 |
Study information
Verified date |
September 2023 |
Source |
Eye Hospital Pristina Kosovo |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Interventional
|
Clinical Trial Summary
Successful treatment of residual refraction 6 months after IOL Implantation with Relex-Smile.
Description:
Residual refractive errors(myopia 50% and hyperopia 30%) are the main problems at patients
after IOL Implantation.
The residual refraction (myopic and hyperopic) after IOL Implantation is difficult to treat
surgically. In addition, there are not many suitable options to offer such patients
presenting with this condition.
Two current common surgeries to treat residual hyperopic refraction are refractive lens
exchange (RLE) and excimer laser ablation (LASIK or PRK).
Laser procedures: Photorefractive keratectomy (PRK); Laser assisted in situ keratomileusis
(LASIK); Risks of LASIK include abnormalities of the corneal flap, epithelial ingrowth,
corneal ectasia, refractive surprises, irregular astigmatism, decentration, visual
aberrations, a loss of BCVA, infectious keratitis, symptoms, and diffuse lamellar keratitis.
Refractive lens exchange (RLE); The risks of RLE are similar to those of cataract surgery and
include endophthalmitis, a loss of accommodation, vitreous loss with posterior capsular
rupture, and retinal detachment.
The aim of our study is to investigate the effect of Relex-Smile to treat the residual
refraction errors (myopia and hypermetropia) 6 months after IOL Implantation.
Before SMILE, Yag-Laser capsulotomy should be performed on all patients, regardless of
posterior capsule ossification, in pseudophakic patients with residual refraction. When the
YAG Laser is applied after the SMILE ,there will be a diopter change. In pseudophakic
patients with hyperopic astigmatism and residual refraction ,corneal topography-guided
intrastromal fresh lenticular implantation should be performed and the lenticule was placed
according to the low K value.
At myopic residual refraction(-0.75D till -5.50D) after IOL Implantation The method used at
the EYE Hospital Pristina by ReLex-SMILE is safe and effective method, since there is no flap
and this prevents invasive damage to the anterior surface of the cornea contrary to the LASIK
where flap is present posing risk for epithelial ingrowth.
At hyperopic residual refraction this study is to investigate the effect of fresh myopic
corneal lenticule implantation as allogenic implant(-1.50D) that will be taken from myopic
patients to implant on Pseudophakic patients with residual hypermetropia refraction (+1.0D)
using VisuMax Femtosecond laser - Smile module surgery